Expression, localisation and function of ACE and chymase in normal and atherosclerotic human coronary arteries

被引:16
作者
Borland, JAA [1 ]
Kelsall, C [1 ]
Yacoub, MH [1 ]
Chester, AH [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Harefield Hosp, Heart Sci Ctr, Natl Heart & Lung Inst,Dept Cardiothorac Surg, Harefield UB9 6JH, Middx, England
关键词
experimental; vasculature; multicellular; pharmacology; ACE inhibitors; coronary circulation; coronary disease; arteries; vasoactive agents;
D O I
10.1016/j.vph.2005.01.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The expression, localisation and function of enzymes responsible for the local formation of angiotensin 11 in atherosclerotic and non-atherosclerotic human coronary arteries were studied. Human epicardial coronary arteries expressed mRNA for both ACE and chymase. Immunobistochemical studies revealed that ACE was localised to the vascular endothelium, and to a lesser extent the medial smooth muscle cells, in both large and small arteries. Chymase was detected in both types of vessel but was shown to be associated with mast cells. The contractions to angiotensin I in large arteries were inhibited only by a combination of quinaprilat and soyabean trypsin inhibitor. In the intramyocardial arteries the response to angiotensin I was markedly inhibited in the presence of chymostatin. These findings demonstrate that a dual pathway for the synthesis of angiotensin II is active in diseased and non-diseased coronary arteries. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:99 / 108
页数:10
相关论文
共 36 条
[1]   ADDITIVE EFFECTS OF COMBINED ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND ANGIOTENSIN-II ANTAGONISM ON BLOOD-PRESSURE AND RENIN RELEASE IN SODIUM-DEPLETED NORMOTENSIVES [J].
AZIZI, M ;
CHATELLIER, G ;
GUYENE, TT ;
MURIETAGEOFFROY, D ;
MENARD, J .
CIRCULATION, 1995, 92 (04) :825-834
[2]  
BALCON R, 1992, CIRCULATION, V86, P100
[3]   Alternative pathways of angiotensin II production in the human saphenous vein [J].
Borland, JAA ;
Chester, AH ;
Morrison, KA ;
Yacoub, MH .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (03) :423-428
[4]   Expression and function of angiotensin converting enzyme, chymase, and angiotensin II in the human radial artery and internal thoracic artery [J].
Borland, JAA ;
Chester, AH ;
Rooker, SJ ;
Wharton, J ;
Davie, N ;
Amrani, M ;
Yacoub, MH .
ANNALS OF THORACIC SURGERY, 2000, 70 (06) :2054-2063
[5]   Chymase-dependent angiotensin II formation in human blood vessels [J].
Chester, AH ;
Borland, JAA .
JOURNAL OF HUMAN HYPERTENSION, 2000, 14 (06) :373-376
[6]   ANTIATHEROGENIC EFFECT OF CAPTOPRIL IN THE WATANABE HERITABLE HYPERLIPIDEMIC RABBIT [J].
CHOBANIAN, AV ;
HAUDENSCHILD, CC ;
NICKERSON, C ;
DRAGO, R .
HYPERTENSION, 1990, 15 (03) :327-331
[7]   AT1 receptor antagonism reduces endothelial dysfunction and intimal thickening in atherosclerotic rabbits [J].
de las Heras, N ;
Aragoncillo, P ;
Maeso, R ;
Vazquez-Pérez, S ;
Navarro-Cid, J ;
DeGasparo, M ;
Mann, J ;
Ruilope, LM ;
Cachofeiro, V ;
Lahera, V .
HYPERTENSION, 1999, 34 (04) :969-975
[8]  
HUBERT C, 1991, J BIOL CHEM, V266, P15377
[9]   Conversion of angiotensin I to angiotensin II by chymase activity in human pulmonary membranes [J].
Lindberg, BF ;
Gyllstedt, E ;
Andersson, KE .
PEPTIDES, 1997, 18 (06) :847-853
[10]   SEASONAL-VARIATION IN THE FUNCTION OF BLOOD MONOCYTES OBTAINED FROM HEALTHY NONSMOKERS, ASYMPTOMATIC SMOKERS, AND SMOKERS WITH CHRONIC-BRONCHITIS [J].
LINDEN, M ;
LARSON, M ;
PRELLNER, T ;
BRATTSAND, R ;
LAITINEN, LA .
CHRONOBIOLOGY INTERNATIONAL, 1994, 11 (04) :266-272